Core from Copper Wolf Source: Buxton Resources
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Buxton Resources (BUX) launches a diamond drilling program at its Copper Wolf project in Arizona, USA
  • The WA-based company has begun drilling its maiden hole, marking the first exploration drilling program in the area since 1993
  • The new hole will target a zone beneath a historical hole that ended in porphyry-style copper-molybdenum mineralisation, with an initial target depth of 1100 metres
  • The company estimates the drilling will take around a month to complete until it reaches its initial target depth
  • Buxton Resources last traded at 20 cents

Buxton Resources (BUX) has launched a diamond drilling program at its Copper Wolf project in Arizona, USA.

The WA-based company has begun drilling its maiden hole, marking the first exploration drilling program in the area since 1993.

The new hole will target a zone beneath a historical hole that ended in porphyry-style copper-molybdenum mineralisation. The drilling is planned to continue roughly 320 metres deeper than the historical hole, with an initial target depth of 1100 metres.

Buxton said it will have the capacity to further extend the hole, if “favourable” mineralisation is intersected.

The exploration drilling will be funded by major shareholder IGO (IGO) as part of a pre-earn-in option, which also includes two of Buxton’s other assets – Narryer and West Kimberley.  

Under the current arrangement, IGO holds an exclusive right to earn a 51 per cent interest in the Copper Wolf tenements by sole funding expenditure totalling $350,000 within two years.

The company estimates the drilling will take around a month to complete until it reaches its initial target depth.

Buxton Resources last traded at 20 cents.

BUX by the numbers
More From The Market Online
The Market Online Video

Daily ASX Market Close: Late run sees market lift 1%, May 31, 2024

The ASX200 took a late uptick to be add almost a per cent at close this…

Little Green Pharma’s cannabis sales leap 30%

Little Green Pharma saw sales leap 30% to $25.6 million in the financial year to March…

Week 22 Wrap: ASX200 anxious; Macquarie see June correction in US markets

The Australian Bureau of Statistics (ABS) has released Australia's latest retail data, showing growth is up…